Background Research into retinal blinding diseases has attracted considerable efforts. Anti-VEGFA antibodies (ranibizumab or Lucentis and bevacizumab or Avastin ) have recently been introduced in the USA and Europe. Although these anti-angiogenic drugs are used successfully for the treatment of wet AMD, they do not address the disease causation. Similarly, other therapeutic interventions to date are palliative for the majority of retinal degenerative diseases. This highlights the need to better understand the etiology of retinal diseases and to inform new approaches for treatment. Results 1. Gene therapy for early congenital blindness (LCA) In collaboration with Peter Colosi's lab (NNRL), we have initiated gene therapy approaches using rd16 mice as a model system. Several methods are employed to accomplish gene delivery into the retina. One approach involves replacement of the defective gene (Cep290). These methods are being first tested by in vivo electroporation and will be followed by subretinal injection of AAV vectors carrying the DNA sequence of interest. 2. Derivation of photoreceptors from human embryonic stem cell (HESC) and Mller glia cell lines Our goal is to develop optimal conditions for photoreceptor differentiation and identify molecular markers for cells that can be used for transplantation. We are using human embryonic stem cells to generate committed photoreceptors and retinal interneurons in vitro. NIH-approved HESC lines were differentiated to retinal cells and transplanted into the subretinal space of young wild type mice to investigate their potential to integrate into the host retina. The adopted protocol reproducibly generated neurons expressing photoreceptor-specific markers after grafting. In future experiments differentiation of HESCs will be accomplished by transfection of recombinant BACmids engineered to express EGFP and tdTomato under control of endogenous photoreceptor gene regulatory elements. Furthermore, we are testing the hypothesis that by introducing NRL in vivo following retinal injury we will enable Mller glia cells to differentiate into rod photoreceptors. Preliminary results obtained by in vivo electroporation of NRL in adult mice were encouraging. More transgenic mice were generated as tools to further test this hypothesis.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAEY000474-01
Application #
7968421
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2009
Total Cost
$1,179,048
Indirect Cost
Name
U.S. National Eye Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Swaroop, Manju; Brooks, Matthew J; Gieser, Linn et al. (2018) Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of Mucopolysaccharidosis I. Hum Mol Genet :
DiStefano, Tyler; Chen, Holly Yu; Panebianco, Christopher et al. (2018) Accelerated and Improved Differentiation of Retinal Organoids from Pluripotent Stem Cells in Rotating-Wall Vessel Bioreactors. Stem Cell Reports 10:300-313
Hoshino, Akina; Ratnapriya, Rinki; Brooks, Matthew J et al. (2017) Molecular Anatomy of the Developing Human Retina. Dev Cell 43:763-779.e4
Yu, Wenhan; Mookherjee, Suddhasil; Chaitankar, Vijender et al. (2017) Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice. Nat Commun 8:14716
Shimada, Hiroko; Lu, Quanlong; Insinna-Kettenhofen, Christine et al. (2017) In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations. Cell Rep 20:384-396
Chen, Yuanyuan; Brooks, Matthew J; Gieser, Linn et al. (2017) Transcriptome profiling of NIH3T3 cell lines expressing opsin and the P23H opsin mutant identifies candidate drugs for the treatment of retinitis pigmentosa. Pharmacol Res 115:1-13
Chen, Holly Yu; Kaya, Koray Dogan; Dong, Lijin et al. (2016) Three-dimensional retinal organoids from mouse pluripotent stem cells mimic in vivo development with enhanced stratification and rod photoreceptor differentiation. Mol Vis 22:1077-1094
Roberts, Lisa; Ratnapriya, Rinki; du Plessis, Morné et al. (2016) Molecular Diagnosis of Inherited Retinal Diseases in Indigenous African Populations by Whole-Exome Sequencing. Invest Ophthalmol Vis Sci 57:6374-6381
Kaewkhaw, Rossukon; Swaroop, Manju; Homma, Kohei et al. (2016) Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines. Invest Ophthalmol Vis Sci 57:ORSFl1-ORSFl11
Charng, Jason; Cideciyan, Artur V; Jacobson, Samuel G et al. (2016) Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration. Hum Mol Genet 25:5444-5459

Showing the most recent 10 out of 18 publications